pNL(CMV)EGFP/CMV/WPRE∆U3 Citations (2)

Originally described in: Specific targeting of human interleukin (IL)-13 receptor alpha2-positive cells with lentiviral vectors displaying IL-13.
Ou W, Marino MP, Suzuki A, Joshi B, Husain SR, Maisner A, Galanis E, Puri RK, Reiser J Hum Gene Ther Methods. 2012 Apr;23(2):137-47. Epub 2012 May 21. PubMed Journal

---

Articles Citing pNL(CMV)EGFP/CMV/WPRE∆U3

Articles
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albarino CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD, Ahmed R. Cell. 2019 May 30;177(6):1566-1582.e17. doi: 10.1016/j.cell.2019.04.036. Epub 2019 May 16. PubMed
A novel imatinib-upregulated long noncoding RNA plays a critical role in inhibition of tumor growth induced by Abl oncogenes. Ma Y, Guo G, Li T, Wen F, Yang J, Chen B, Wang X, Chen JL. Mol Cancer. 2022 Jan 3;21(1):5. doi: 10.1186/s12943-021-01478-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.